Pharma & Bio
Technology
“Animal testing alone is not enough”… HLB BioStep Expands Next-Generation Preclinical Platform
As interest grows in next-generation preclinical evaluation technologies that can replace animal testing in the global pharmaceutical industry, the business model of #HLB BioStep, a contract research …
Technology
Pharos Soars on Nvidia Link, Daewon Tops KOSPI [K-Bio Pulse]
South Korean pharmaceutical and biotech stocks staged a rare broad-based rally on Aug. 5 as investor sentiment lifted shares across multiple sectors.As Nvidia CEO Jensen Huang’s visit to South Korea f…
Technology
“From Jensen Huang-themed stocks to new obesity drugs”… CoreLine, Daewon, and Pharos on the rise [Bio Spotlight]
On the 5th, domestic pharmaceutical and biotech stocks showed a rare simultaneous surge. As investor sentiment flocked to artificial intelligence (AI)-related stocks following the visit to South Korea…
Lifestyle
“Send in a stool sample and AI will recommend supplements”… CJ Basa Sets Sights on the GLP-1 Era
“We are no longer in an era where people can just take any probiotic. An era is coming where AI analyzes a customer’s gut microbiome and recommends the most suitable nutrients.”As the global healthcar…
Technology
D&D Pharmatech Rises on Hopes of a Major Deal; Aimed Bio and ImmuneOncia Slide [K-Bio Pulse]
D&D Pharmatech Inc. stood out in a weak biotech market on June 4, surging on expectations for a potential licensing deal related to metabolic dysfunction-associated steatohepatitis (MASH). In contrast…
Technology
D&D Pharmatech Rises on Big Deal Expectations… Aimed Bio and Immune Oncia Down [Bio Market Watch]
On the 4th, in the biotech and healthcare sector, #DNDPharmatech surged on expectations of a technology transfer related to metabolic dysfunction-associated steatohepatitis (MASH), making its presence…
Technology
Pharos iBio Joins Eli Lilly’s ‘TuneLab’… to Utilize NVIDIA AI Platform [Exclusive to Edaily]
#Pharos iBio, a South Korean company specializing in AI-driven drug discovery, has joined forces with global pharmaceutical giant Eli Lilly. Pharos iBio has officially signed a strategic cooperation a…
Lifestyle
“Enaprazu Selling Out Due to High Demand”… Bivon Pharmaceutical to Produce 120,000 Additional Vials [Bio Spotlight]
On the 2nd, companies in the domestic pharmaceutical and biotech industry drew market attention for their successive achievements, including clinical progress, expanded production, and major technolog…
Business·Industry
Hong Jong-ho, CEO of KUKJEON: “We’re Making a Bold Move to Expand Our Business into Advanced Materials, from Active Pharmaceutical Ingredients to AI Semiconductor Packaging”
“KUKJEON PHARMACEUTICAL Co.,Ltd(307750)is a company that is extending new branches into fine chemicals and materials while remaining rooted in its core business of pharmaceuticals.”
Hong Jong-ho, C…
Lifestyle
Only the Core Technology Survives as AI-Labeled Biotech Companies Fade Away
Global capital markets are growing increasingly wary of so-called “AI washing.” As companies that have lured investors by touting AI technology find themselves in the crosshairs of judicial authoritie…